Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wolter

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Investigational New Drugs|January 1, 1983
A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanomaJ C Arseneau, J M Wolter, M Kuperminc, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II study of m-AMSA in advances malignant melanomaJ C Arseneau, J M Wolter, J C Probert, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 4, 2001
[Plantar fibromatosis with marked cutaneous involvement]H L de Almeida, M Wolter, M G Neugebauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 1991
[Congenital poikiloderma syndrome with early childhood blister formation (Brain syndrome) and unusual associated neurologic symptoms]A Mayet, W C Marsch, M Wolter, et al.
Clinical and Diagnostic Laboratory Immunology|March 6, 1999
Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosisJ M Wolter, R L Rodwell, S D Bowler, et al.
The British Journal of Dermatology|February 21, 1998
The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girlU M Niemczyk, T M Zollner, M Wolter, et al.
Der Urologe. Ausg. A|February 3, 2005
[Silica-containing urinary stones--clinical issues to keep in mind]M May, C Helke, K Kubenz, et al.
The European Respiratory Journal|April 1, 1997
Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspectsJ M Wolter, S D Bowler, P J Nolan, et al.
Archives of Dermatological Research|April 9, 1999
The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugsW H Boehncke, M Kock, K Hardt-Weinelt, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 1999
Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumorsK Husemann, M Wolter, R Büschges, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Investigational New Drugs|January 1, 1983
A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanomaJ C Arseneau, J M Wolter, M Kuperminc, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II study of m-AMSA in advances malignant melanomaJ C Arseneau, J M Wolter, J C Probert, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 4, 2001
[Plantar fibromatosis with marked cutaneous involvement]H L de Almeida, M Wolter, M G Neugebauer, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 1991
[Congenital poikiloderma syndrome with early childhood blister formation (Brain syndrome) and unusual associated neurologic symptoms]A Mayet, W C Marsch, M Wolter, et al.
Clinical and Diagnostic Laboratory Immunology|March 6, 1999
Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosisJ M Wolter, R L Rodwell, S D Bowler, et al.
The British Journal of Dermatology|February 21, 1998
The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girlU M Niemczyk, T M Zollner, M Wolter, et al.
Der Urologe. Ausg. A|February 3, 2005
[Silica-containing urinary stones--clinical issues to keep in mind]M May, C Helke, K Kubenz, et al.
The European Respiratory Journal|April 1, 1997
Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspectsJ M Wolter, S D Bowler, P J Nolan, et al.
Archives of Dermatological Research|April 9, 1999
The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugsW H Boehncke, M Kock, K Hardt-Weinelt, et al.
Journal of Neuropathology and Experimental Neurology|October 9, 1999
Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumorsK Husemann, M Wolter, R Büschges, et al.
Pageof 22